Skip to Content

  • Search

View Additional Section Content

PrECOG - PrE0501 - A Randomized Phase II Study Evaluating Vandetanib (ZD6474) in Combination with Docetaxel and Carboplatin +/- Placebo or Maintenance Therapy with Vandetanib in Patients with IIIb, IV or Recurrent Non-Small Cell Lung Cancer (NSCLC). Accrual limited to Abington Cancer Care Specialists.

Clinical Trial Categories

  • Lung Cancer
The Rosenfeld Cancer Center at 215-481-2402


  • The Rosenfeld Cancer Center

Find a Physician
Search Our Directory


Schedule a Test
Request an Appointment


Clinical Trials Details